← Eichor
Study identifier: NCT07697495 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Scapulothoracic Stabilization and Postural Training in Upper Extremity Lymphedema

Condition: Secondary Lymphedema  ·  Sponsor: Toros University

PhaseNA
Planned participants60
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

This single-center randomized controlled trial aims to investigate the effects of adding scapulothoracic stabilization and postural training to standard lymphedema care in women with secondary upper extremity lymphedema following breast cancer surgery. Participants will be randomly assigned to receive either standard lymphedema care alone or standard care combined with scapulothoracic stabilization and postural training. Outcomes including scapular muscle strength, posture, upper extremity function, limb volume, and neck awareness will be assessed at baseline, immediately after treatment, and at a 2-month follow-up. The findings are expected to provide evidence regarding the effectiveness of incorporating targeted stabilization and postural exercises into conventional lymphedema rehabilitation.

This description comes directly from the study's public registry record.

Talk to the study team

İdil Esin Ünlü, Assist. Prof. Dr.  ·  +90 506 515 66 22  ·  idil.unlu@toros.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Adana Şehir Eğitim ve Araştırma HastanesiAdana, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07697495